This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: National Institute of Infectious Diseases, Toray Industries, Inc.. Active years: 2015.
Company Filing History:
1 out of 37 
1 out of 3,572 
Years Active: 2015
Title: Yuko Akazawa: Innovator in Hepatitis C Research
Introduction
Yuko Akazawa is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of medical research, particularly in the study of hepatitis C virus (HCV). Her innovative work has led to the development of a unique antibody that plays a crucial role in identifying different genotypes of the virus.
Latest Patents
Yuko Akazawa holds a patent titled "Antibody binding to envelope protein 2 of hepatitis C virus and method for identifying genotype of hepatitis C virus using the same." This invention provides an antibody that specifically binds to envelope protein 2 of HCV of genotype 2 but does not immunologically react with envelope protein 2 of HCV of genotype 1. This specificity is vital for accurate diagnosis and treatment of hepatitis C.
Career Highlights
Throughout her career, Yuko has worked with esteemed organizations such as Toray Industries, Inc. and the National Institute of Infectious Diseases. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Yuko has collaborated with notable colleagues, including Noriko Nakamura and Takaji Wakita. These partnerships have enhanced her research efforts and expanded the impact of her work in the scientific community.
Conclusion
Yuko Akazawa's contributions to hepatitis C research exemplify the importance of innovation in medical science. Her patented work on antibodies has the potential to improve diagnostic methods and treatment options for patients worldwide.